Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

Bibliographic Details
Main Authors: Matteo Centonze, Giusy Di Conza, Michael Lahn, Isabel Fabregat, Francesco Dituri, Isabella Gigante, Grazia Serino, Rosanna Scialpi, Livianna Carrieri, Roberto Negro, Elena Pizzuto, Gianluigi Giannelli
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:https://doi.org/10.1186/s13046-023-02797-9
_version_ 1797451036051374080
author Matteo Centonze
Giusy Di Conza
Michael Lahn
Isabel Fabregat
Francesco Dituri
Isabella Gigante
Grazia Serino
Rosanna Scialpi
Livianna Carrieri
Roberto Negro
Elena Pizzuto
Gianluigi Giannelli
author_facet Matteo Centonze
Giusy Di Conza
Michael Lahn
Isabel Fabregat
Francesco Dituri
Isabella Gigante
Grazia Serino
Rosanna Scialpi
Livianna Carrieri
Roberto Negro
Elena Pizzuto
Gianluigi Giannelli
author_sort Matteo Centonze
collection DOAJ
first_indexed 2024-03-09T14:49:09Z
format Article
id doaj.art-3860ae793f9c47ad98e64cca50461ccd
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-03-09T14:49:09Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-3860ae793f9c47ad98e64cca50461ccd2023-11-26T14:34:30ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-08-014211110.1186/s13046-023-02797-9Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical modelsMatteo Centonze0Giusy Di Conza1Michael Lahn2Isabel Fabregat3Francesco Dituri4Isabella Gigante5Grazia Serino6Rosanna Scialpi7Livianna Carrieri8Roberto Negro9Elena Pizzuto10Gianluigi Giannelli11National Institute of Gastroenterology - IRCCS “Saverio de Bellis”iOnctura SAiOnctura SATGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBEREHD ? ISCIIINational Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”National Institute of Gastroenterology - IRCCS “Saverio de Bellis”https://doi.org/10.1186/s13046-023-02797-9
spellingShingle Matteo Centonze
Giusy Di Conza
Michael Lahn
Isabel Fabregat
Francesco Dituri
Isabella Gigante
Grazia Serino
Rosanna Scialpi
Livianna Carrieri
Roberto Negro
Elena Pizzuto
Gianluigi Giannelli
Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
Journal of Experimental & Clinical Cancer Research
title Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
title_full Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
title_fullStr Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
title_full_unstemmed Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
title_short Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
title_sort correction autotaxin inhibitor ioa 289 reduces gastrointestinal cancer progression in preclinical models
url https://doi.org/10.1186/s13046-023-02797-9
work_keys_str_mv AT matteocentonze correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT giusydiconza correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT michaellahn correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT isabelfabregat correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT francescodituri correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT isabellagigante correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT graziaserino correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT rosannascialpi correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT liviannacarrieri correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT robertonegro correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT elenapizzuto correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels
AT gianluigigiannelli correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels